Dermatology Doctors in Spanish Fork, UT Accepting Medicare

5 Dermatology doctors found. Showing 1 - 5

Dr. Michael P Eyre, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 114 E 800 N, Spanish Fork, UT 84660 Phone: 801-794-1490    Fax: 801-794-1495

Dr. Warren Albert Peterson, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 78 East 900 North, Spanish Fork, UT 84660 Phone: 801-794-1490

Meredith A. Gaufin, MD Dermatology Medicare: Medicare Enrolled Practice Location: 819 E Market Place Dr, Spanish Fork, UT 84660 Phone: 801-357-7280

Dr. Michael Warren Peterson, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 114 East 800 North, Spanish Fork, UT 84660 Phone: 801-794-1490    Fax: 801-794-1495

Dr. Chad Peterson, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 114 E 800 N, Spanish Fork, UT 84660 Phone: 801-794-1490    Fax: 801-794-1495

News Archive

A new significance of LVD and angiogenic MVD is identified in human primary SCRC

Lymphangiogenesis and angiogenesis are critical processes for tumor growth, invasion and metastasis.

Young adults living in states with more liberal policies report higher rates of cannabis use

Adolescents and young adults living in states with more liberal policies reported higher average rates of past-year cannabis use than those in states with more conservative policies, according to a new study conducted at Columbia University Mailman School of Public Health.

Children's weight associated with their math performance

Obesity among children has increased dramatically over the past 40 years and has been tied to many health problems. Now a new study has found that children's weight is associated with their math performance.

TYRX's AIGISRx R Antibacterial Envelope technology gets FDA clearance

TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance to market the Fully Resorbable AIGISRx R Antibacterial Envelope for use with pacemakers and implantable cardioverter defibrillators.

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

AbbVie presented new results from the Phase 3 GIFT-I study of its investigational, all-oral, interferon (IFN)- and ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan Society of Hepatology in Kumamoto, Japan.

Read more Medical News

› Verified 3 days ago